• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
BZW2 promotes malignant progression in lung adenocarcinoma through enhancing the ubiquitination and degradation of GSK3β.BZW2通过增强GSK3β的泛素化和降解促进肺腺癌的恶性进展。
Cell Death Discov. 2024 Feb 29;10(1):105. doi: 10.1038/s41420-024-01879-7.
2
Prognostic significance of BZW2 expression in lung adenocarcinoma patients.BZW2表达在肺腺癌患者中的预后意义
Int J Clin Exp Pathol. 2019 Dec 1;12(12):4289-4296. eCollection 2019.
3
BZW2 Modulates Lung Adenocarcinoma Progression through Glycolysis-Mediated IDH3G Lactylation Modification.BZW2 通过糖酵解介导的 IDH3G 乳酰化修饰调节肺腺癌进展。
J Proteome Res. 2023 Dec 1;22(12):3854-3865. doi: 10.1021/acs.jproteome.3c00518. Epub 2023 Nov 13.
4
BZW2 promotes the malignant progression of colorectal cancer via activating the ERK/MAPK pathway.BZW2 通过激活 ERK/MAPK 通路促进结直肠癌的恶性进展。
J Cell Physiol. 2020 May;235(5):4834-4842. doi: 10.1002/jcp.29361. Epub 2019 Oct 23.
5
Expression, oncological and immunological characterizations of BZW1/2 in pancreatic adenocarcinoma.BZW1/2在胰腺腺癌中的表达、肿瘤学及免疫学特征
Front Genet. 2022 Oct 4;13:1002673. doi: 10.3389/fgene.2022.1002673. eCollection 2022.
6
The Prognostic and Immune Significance of BZW2 in Pan-Cancer and its Relationship with Proliferation and Apoptosis of Cervical Cancer.BZW2 在泛癌中的预后和免疫意义及其与宫颈癌增殖和凋亡的关系。
Front Biosci (Landmark Ed). 2024 Mar 11;29(3):97. doi: 10.31083/j.fbl2903097.
7
Role of the novel gene BZW2 in the development of hepatocellular carcinoma.新基因BZW2在肝细胞癌发生发展中的作用
J Cell Physiol. 2019 Sep;234(9):16592-16600. doi: 10.1002/jcp.28331. Epub 2019 Feb 25.
8
BZW2/5MP1 acts as a promising target in hepatocellular carcinoma.BZW2/5MP1在肝细胞癌中是一个很有前景的靶点。
J Cancer. 2021 Jun 22;12(17):5125-5135. doi: 10.7150/jca.53282. eCollection 2021.
9
HIF-1ɑ-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt/β-catenin and Notch signaling.HIF-1α 调控的 miR-1275 通过同时激活 Wnt/β-catenin 和 Notch 信号通路来维持肺癌干细胞样表型并促进 LUAD 的进展。
Theranostics. 2020 Jan 22;10(6):2553-2570. doi: 10.7150/thno.41120. eCollection 2020.
10
LINC00491 Facilitates Tumor Progression of Lung Adenocarcinoma via Wnt/β-Catenin-Signaling Pathway by Regulating MTSS1 Ubiquitination.LINC00491 通过调控 MTSS1 泛素化来促进肺腺癌的肿瘤进展,该过程涉及 Wnt/β-连环蛋白信号通路。
Cells. 2022 Nov 23;11(23):3737. doi: 10.3390/cells11233737.

引用本文的文献

1
Glycogen synthase kinase 3β: a key player in progressive chronic kidney disease.糖原合酶激酶3β:进行性慢性肾病的关键因素
Clin Sci (Lond). 2025 Jun 17;139(12):605-25. doi: 10.1042/CS20245219.
2
RacGAP1 Plays an Oncogenic Role in Lung Adenocarcinoma by Regulating the Wnt/β-Catenin Pathway.RacGAP1通过调节Wnt/β-连环蛋白信号通路在肺腺癌中发挥致癌作用。
Cells. 2025 May 23;14(11):773. doi: 10.3390/cells14110773.
3
Identification and validation of USP15 and CUL2 as ubiquitination related biomarker in chronic obstructive pulmonary disease.

本文引用的文献

1
HSPB1 facilitates chemoresistance through inhibiting ferroptotic cancer cell death and regulating NF-κB signaling pathway in breast cancer.热休克蛋白家族成员 B1(HSPB1)通过抑制铁死亡和调控 NF-κB 信号通路促进乳腺癌的化疗耐药。
Cell Death Dis. 2023 Jul 15;14(7):434. doi: 10.1038/s41419-023-05972-0.
2
BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis.BZW2 抑制可降低结直肠癌生长和转移。
Mol Cancer Res. 2023 Jul 5;21(7):698-712. doi: 10.1158/1541-7786.MCR-23-0003.
3
Circ-GSK3B up-regulates GSK3B to suppress the progression of lung adenocarcinoma.
鉴定和验证USP15和CUL2作为慢性阻塞性肺疾病中泛素化相关生物标志物
Hereditas. 2025 May 24;162(1):86. doi: 10.1186/s41065-025-00460-1.
环状 RNA-GSK3B 通过上调 GSK3B 抑制肺腺癌的进展。
Cancer Gene Ther. 2022 Nov;29(11):1761-1772. doi: 10.1038/s41417-022-00489-8. Epub 2022 Jul 11.
4
Arterial Stiffness and the Canonical WNT/β-catenin Pathway.动脉僵硬度与经典 WNT/β-连环蛋白通路。
Curr Hypertens Rep. 2022 Nov;24(11):499-507. doi: 10.1007/s11906-022-01211-7. Epub 2022 Jun 21.
5
Phosphorylation-Dependent Regulation of WNT/Beta-Catenin Signaling.WNT/β-连环蛋白信号通路的磷酸化依赖性调控
Front Oncol. 2022 Mar 14;12:858782. doi: 10.3389/fonc.2022.858782. eCollection 2022.
6
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities.Wnt/β-catenin 信号通路:功能、生物学机制与治疗机会。
Signal Transduct Target Ther. 2022 Jan 3;7(1):3. doi: 10.1038/s41392-021-00762-6.
7
Negatively Regulated by miR-29c-3p, MTFR1 Promotes the Progression and Glycolysis in Lung Adenocarcinoma the AMPK/mTOR Signalling Pathway.MTFR1受miR-29c-3p负调控,通过AMPK/mTOR信号通路促进肺腺癌进展及糖酵解
Front Cell Dev Biol. 2021 Dec 1;9:771824. doi: 10.3389/fcell.2021.771824. eCollection 2021.
8
Wnt/β-catenin signaling in cancers and targeted therapies.Wnt/β-连环蛋白信号通路在癌症和靶向治疗中的作用。
Signal Transduct Target Ther. 2021 Aug 30;6(1):307. doi: 10.1038/s41392-021-00701-5.
9
Human oncoprotein 5MP suppresses general and repeat-associated non-AUG translation via eIF3 by a common mechanism.人类癌蛋白5MP通过一种共同机制,经由真核起始因子3(eIF3)抑制一般翻译和重复序列相关的非AUG起始的翻译。
Cell Rep. 2021 Jul 13;36(2):109376. doi: 10.1016/j.celrep.2021.109376.
10
The Role of miR-640: A Potential Suppressor in Breast Cancer Wnt7b/β-catenin Signaling Pathway.miR-640的作用:乳腺癌Wnt7b/β-连环蛋白信号通路中的潜在抑制因子
Front Oncol. 2021 Apr 12;11:645682. doi: 10.3389/fonc.2021.645682. eCollection 2021.

BZW2通过增强GSK3β的泛素化和降解促进肺腺癌的恶性进展。

BZW2 promotes malignant progression in lung adenocarcinoma through enhancing the ubiquitination and degradation of GSK3β.

作者信息

Jin Kai, Li Yongmeng, Wei Ruyuan, Liu Yanfei, Wang Shuai, Tian Hui

机构信息

Department of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, China.

Department of Thoracic Surgery, the First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China.

出版信息

Cell Death Discov. 2024 Feb 29;10(1):105. doi: 10.1038/s41420-024-01879-7.

DOI:10.1038/s41420-024-01879-7
PMID:38424042
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10904796/
Abstract

The role of Basic leucine zipper and W2 domains 2 (BZW2) in the advancement of different types of tumors is noteworthy, but its involvement and molecular mechanisms in lung adenocarcinoma (LUAD) remain uncertain. Through this investigation, it was found that the upregulation of BZW2 was observed in LUAD tissues, which was associated with an unfavorable prognosis for individuals diagnosed with LUAD, as indicated by data from Gene Expression Omnibus and The Cancer Genome Atlas databases. Based on the clinicopathologic characteristics of LUAD patients from the tissue microarray, both univariate and multivariate analyses indicated that BZW2 functioned as an independent prognostic factor for LUAD. In terms of mechanism, BZW2 interacted with glycogen synthase kinase-3 beta (GSK3β) and enhanced the ubiquitination-mediated degradation of GSK3β through slowing down of the dissociation of the ubiquitin ligase complex, which consists of GSK3β and TNF receptor-associated factor 6. Moreover, BZW2 stimulated Wnt/β-catenin signaling pathway through GSK3β, thereby facilitating the advancement of LUAD. In conclusion, BZW2 was a significant promoter of LUAD. The research we conducted identified a promising diagnostic and therapeutic target for LUAD.

摘要

碱性亮氨酸拉链和W2结构域2(BZW2)在不同类型肿瘤进展中的作用值得关注,但其在肺腺癌(LUAD)中的参与情况和分子机制仍不明确。通过本研究发现,在LUAD组织中观察到BZW2上调,基因表达综合数据库和癌症基因组图谱数据库的数据表明,这与LUAD诊断患者的不良预后相关。基于组织芯片中LUAD患者的临床病理特征,单因素和多因素分析均表明BZW2是LUAD的独立预后因素。在机制方面,BZW2与糖原合酶激酶-3β(GSK3β)相互作用,并通过减缓由GSK3β和肿瘤坏死因子受体相关因子6组成的泛素连接酶复合物的解离,增强GSK3β的泛素化介导降解。此外,BZW2通过GSK3β刺激Wnt/β-连环蛋白信号通路,从而促进LUAD的进展。总之,BZW2是LUAD的重要促进因子。我们进行的研究确定了一个有前景的LUAD诊断和治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4393/10904796/dfdf30362036/41420_2024_1879_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4393/10904796/260a3c320bc0/41420_2024_1879_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4393/10904796/145095da4d92/41420_2024_1879_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4393/10904796/3b074184498e/41420_2024_1879_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4393/10904796/aa2502dc2ecf/41420_2024_1879_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4393/10904796/69d22593d79a/41420_2024_1879_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4393/10904796/dfdf30362036/41420_2024_1879_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4393/10904796/260a3c320bc0/41420_2024_1879_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4393/10904796/145095da4d92/41420_2024_1879_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4393/10904796/3b074184498e/41420_2024_1879_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4393/10904796/aa2502dc2ecf/41420_2024_1879_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4393/10904796/69d22593d79a/41420_2024_1879_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4393/10904796/dfdf30362036/41420_2024_1879_Fig6_HTML.jpg